Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Teva
Julphar
Citi
QuintilesIMS
Colorcon
Argus Health
Chubb
Chinese Patent Office

Generated: February 19, 2019

DrugPatentWatch Database Preview

JETREA Drug Profile

« Back to Dashboard

Summary for Tradename: JETREA
Patents:8
Applicants:1
BLAs:1
Suppliers: see list1
Pharmacology for JETREA
Ingredient-typePeptide Hydrolases

US Patents for JETREA

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Thrombogenics, Inc JETREA ocriplasmin INJECTABLE; INTRAVITREAL 125422 001 2012-10-17 ➤ Sign Up Thromb-X nv (Leuven, BE) ➤ Sign Up RX company
Thrombogenics, Inc JETREA ocriplasmin INJECTABLE; INTRAVITREAL 125422 001 2012-10-17 ➤ Sign Up ThromboGenics NV (Leuven, BE) ➤ Sign Up RX company
Thrombogenics, Inc JETREA ocriplasmin INJECTABLE; INTRAVITREAL 125422 001 2012-10-17 ➤ Sign Up ThromboGenics NV (Heverlee, BE) ➤ Sign Up RX company
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for JETREA

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1390041-0 Sweden ➤ Sign Up PRODUCT NAME: MIKROPLASMIN; REG. NO/DATE: EU/1/13/819/001 20130313
13C0052 France ➤ Sign Up PRODUCT NAME: MICROPLASMINE; REGISTRATION NO/DATE: EU/1/13/819/001 20130313
PA2013020,C1581254 Lithuania ➤ Sign Up PRODUCT NAME: OCRIPLASMINUM (MICROPLASMINUM); REGISTRATION NO/DATE: EU/1/13/819/001 20130313
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Healthtrust
Deloitte
Express Scripts
Julphar
Merck
Argus Health
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.